REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 29 filers reported holding REXAHN PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $16,000 | +14.3% | 30,818 | +112.9% | 0.00% | – |
| Q4 2018 | $14,000 | +7.7% | 14,476 | +91.7% | 0.00% | – |
| Q3 2018 | $13,000 | +225.0% | 7,551 | +202.0% | 0.00% | – |
| Q2 2018 | $4,000 | -63.6% | 2,500 | -65.8% | 0.00% | – |
| Q1 2018 | $11,000 | +450.0% | 7,303 | +659.9% | 0.00% | – |
| Q4 2017 | $2,000 | – | 961 | +2084.1% | 0.00% | – |
| Q2 2017 | $0 | – | 44 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 169,901 | $411,000 | 0.03% |
| Benin Management CORP | 14,300 | $35,000 | 0.01% |
| Northeast Financial Consultants Inc | 15,000 | $36,000 | 0.01% |
| WEDBUSH SECURITIES INC | 25,500 | $62,000 | 0.01% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 49,167 | $119,000 | 0.00% |
| Renaissance Technologies | 344,299 | $833,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 8,238 | $20,000 | 0.00% |
| NORTHERN TRUST CORP | 47,859 | $116,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 28 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 146,083 | $353,000 | 0.00% |